PAPER Fortress AM, Buhusi M, Helke KL, Granholm AC
SEARCH RESULTS
331007 RESULTS
PAPER Alexopoulos P, Sorg C, Förschler A, Grimmer T, Skokou M, Wohlschläger A, Perneczky R, Zimmer C, Kurz A, Preibisch C
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI.
Eur Arch Psychiatry Clin Neurosci. 2011 Jul 24; PubMed: 21786091PAPER Müller M, Cárdenas C, Mei L, Cheung KH, Foskett JK
Constitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling.
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13293-8. PubMed: 21784978PAPER Chakroborty S, Stutzmann GE
Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction.
Sci China Life Sci. 2011 Aug;54(8):752-62. PubMed: 21786198PAPER Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJ
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.
Alzheimers Dement. 2011 Jul;7(4):367-85. PubMed: 21784348PAPER Gustavsson A, Cattelin F, Jönsson L
Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants.
Alzheimers Dement. 2011 Jul;7(4):466-73. PubMed: 21784355PAPER Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, Ismail MS, Martin BK, Mullan MJ, Sabbagh M, Tariot PN,
Extended results of the Alzheimer's disease anti-inflammatory prevention trial.
Alzheimers Dement. 2011 Jul;7(4):402-11. PubMed: 21784351PAPER Scheltens P, Rockwood K
How golden is the gold standard of neuropathology in dementia?
Alzheimers Dement. 2011 Jul;7(4):486-9. PubMed: 21784357PAPER Zhou ZD, Chan CH, Ma QH, Xu XH, Xiao ZC, Tan EK
The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.
Cell Adh Migr. 2011 Jul 1;5(4):280-92. PubMed: 21785276PAPER Garand L, Dew MA, Lingler JH, Dekosky ST
Incidence and predictors of advance care planning among persons with cognitive impairment.
Am J Geriatr Psychiatry. 2011 Aug;19(8):712-20. PubMed: 21785291PAPER Tiraboschi P, Chitò E, Sacco L, Sala M, Stefanini S, Defanti CA
Evaluating voting competence in persons with Alzheimer disease.
Int J Alzheimers Dis. 2011;2011:983895. PubMed: 21785703PAPER Corey-Bloom J
Treatment Trials in Aging and Mild Cognitive Impairment.
Curr Top Behav Neurosci. 2011 Jul 22; PubMed: 21786037PAPER Supnet C, Bezprozvanny I
Presenilins as endoplasmic reticulum calcium leak channels and Alzheimer's disease pathogenesis.
Sci China Life Sci. 2011 Aug;54(8):744-51. PubMed: 21786197Brian Downer
University of KentuckyWallis and Futuna
Jacobo E. Mintzer on Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging.
COMMENT This is really interesting and goes against the usual interpretation that increased blood glucose due to poor sugar control will lead to increases in AD. We have noticed a similar trend, showing that poor glucose control (high blood glucose) results in re
Current Filters
No filters selected